TABLE 1 WORLDWIDE SCENARIO FOR CHRONIC DISEASES CAUSING DEATH
TABLE 2 TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 20152022 ($MILLION)
TABLE 3 TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET, BY GEOGRAPHY, 20152022 ($MILLION)
TABLE 4 NON-MOLECULAR ASSAYS MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 5 NON-MOLECULAR ASSAYS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 6 SEROLOGICAL ASSAYS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 7 WORLD MIXED LYMPHOCYTE CULTURE ASSAYS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 8 MOLECULAR ASSAYS TECHNOLOGY MARKET, 20142022 ($MILLION)
TABLE 9 MOLECULAR ASSAYS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 10 PCR-BASED MOLECULAR ASSAY, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 11 SEQUENCING-BASED MOLECULAR ASSAY, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 12 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY COMPONENT, 20142022 ($MILLION)
TABLE 13 WORLD TRANSPLANT DIAGNOSTICS COMPONENT MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 14 WORLD TRANSPLANT CONSUMABLES MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 15 WORLD TRANSPLANT DIAGNOSTICS INSTRUMENTS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 16 WORLD TRANSPLANT DIAGNOSTICS SOFTWARE MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 17 WORLD TRANSPLANT DIAGNOSTICS SERVICES MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 18 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 20142022 ($MILLION)
TABLE 19 WORLD TRANSPLANT DIAGNOSTICS END USER MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 20 WORLD HOSPITALS AND TRANSPLANT CENTERS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 21 WORLD RESEARCH LABORATORIES AND ACADEMIC INSTITUTIONS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 22 WORLD COMMERCIAL SERVICE PROVIDERS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 23 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATIONS, 20142022 ($MILLION)
TABLE 24 WORLD TRANSPLANT DIAGNOSTICS APPLICATIONS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 25 WORLD RESEARCH MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 26 WORLD DIAGNOSTICS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 27 TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE, 20142022 ($MILLION)
TABLE 28 TRANSPLANT DIAGNOSTICS ORGAN TYPE MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 29 TRANSPLANT DIAGNOSTICS MARKET FOR KIDNEY, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 30 TRANSPLANT DIAGNOSTICS MARKET FOR LIVER, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 31 TRANSPLANT DIAGNOSTICS MARKET FOR HEART, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 32 TRANSPLANT DIAGNOSTICS MARKET FOR LUNGS, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 33 TRANSPLANT DIAGNOSTICS MARKET FOR PANCREAS, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 34 WORLD TRANSPLANT DIAGNOSTICS MARKET FOR OTHER ORGANS, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 35 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY TYPE OF SCREENING, 20142022 ($MILLION)
TABLE 36 WORLD TRANSPLANT DIAGNOSTICS SCREENING MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 37 WORLD PRE-SCREENING MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 38 WORLD POST-SCREENING MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 39 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 20142022 ($MILLION)
TABLE 40 NORTH AMERICAN TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 20142022 ($MILLION)
TABLE 41 NORTH AMERICAN TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 42 EUROPEAN TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 20142022 ($MILLION)
TABLE 43 EUROPEAN TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 44 ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 45 ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 46 LAMEA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT, 20142022 ($MILLION)
TABLE 47 LAMEA TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 49 IMMUCOR: OPERATING SEGMENTS
TABLE 51 BIO-RAD: OPERATING SEGMENTS
TABLE 53 THERMO FISHER: OPERATING SEGMENTS
TABLE 55 ROCHE: OPERATING SEGMENTS
TABLE 57 ILLUMINA: OPERATING SEGMENTS
TABLE 59 ABBOTT: OPERATING SEGMENTS
TABLE 61 SIGMA-ALDRICH: OPERATING SEGMENTS
TABLE 63 QIAGEN N.V.: OPERATING SEGMENTS
TABLE 66 DIASORIN: OPERATING SEGMENTS

LIST OF FIGURE

FIG. 1 TOP INVESTMENT POCKETS IN WORLD TRANSPLANT DIAGNOSTICS MARKET
FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (20112016)
FIG. 3 TOP WINNING STRATEGIES: NATURE & TYPE
FIG. 4 PORTERS FIVE FORCES ANALYSIS
FIG. 5 TRANSPLANT DIAGNOSTICS MARKET TOP PLAYER POSITIONING, 2015
FIG. 6 WORLD GERIATRIC POPULATION, BY REGION, 2015
FIG. 7 TRANSPLANT PROCEDURES IN THE U.S., BY AGE, 2015
FIG. 8 WAITING LIST IN U.S. FOR ORGAN TRANSPLANTATION BY TYPE OF ORGAN
FIG. 9 U.S.: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 10 CANADA: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 11 MEXICO: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 12 U.K.: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 13 GERMANY: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 14 FRANCE: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 15 SPAIN: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 16 ITALY: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 17 TURKEY: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 18 REST OF EUROPE: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 19 AUSTRALIA: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 20 SOUTH KOREA: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 21 NEW ZEALAND: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 22 CHINA: TRANSPLANT DIAGNOSTICS MARKET, (20142022) ($MILLION)
FIG. 23 JAPAN: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 24 REST OF ASIA-PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, (20142022) ($MILLION)
FIG. 25 BRAZIL: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 26 ISRAEL: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 27 IRAN: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 28 SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 29 REST OF LAMEA TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)
FIG. 30 IMMUCOR: REVENUE, 20132015, ($MILLION)
FIG. 31 IMMUCOR: REVENUE, BY BUSINESS SEGMENT, 2015(%)
FIG. 32 IMMUCOR: REVENUE, BY GEOGRAPHY, 2015, (%)
FIG. 33 BIO-RAD: SALES, 20132015, ($MILLION)
FIG. 34 BIO-RAD: SALES, BY BUSINESS SEGMENT, 2015 (%)
FIG. 35 BIO-RAD: SALES, BY GEOGRAPHY, 2015(%)
FIG. 36 THERMO FISHER: REVENUE, 20132015 ($MILLION)
FIG. 37 THERMO FISHER: REVENUE, BY BUSINESS SEGMENT, 2015, (%)
FIG. 38 THERMO FISHER: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 39 ROCHE: REVENUE, 20132015 ($MILLION)
FIG. 40 ROCHE: REVENUE, BY BUSINESS SEGMENT, 2015(%)
FIG. 41 ROCHE: REVENUE, BY GEOGRAPHY, 2015(%)
FIG. 42 ILLUMINA: REVENUE, 20132015 ($MILLION)
FIG. 43 ILLUMINA: REVENUE, BY SEGEMNT, 2015 (%)
FIG. 44 ILLUMINA: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 45 ABBOTT: REVENUE, 20132015 ($MILLION)
FIG. 46 ABBOTT: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 47 ABBOTT: REVENUE, BY GEOGRAPHY, 20132015 ($MILLION)
FIG. 48 SIGMA-ALDRICH: REVENUE, 20132014 ($MILLION)
FIG. 49 SIGMA-ALDRICH: REVENUE, BY BUSINESS UNITS, 2014 (%)
FIG. 50 SIGMA-ALDRICH: REVENUE, BY GEOGRAPHY, 2014 (%)
FIG. 51 QIAGEN N.V.: REVENUE, 20132015 ($MILLION)
FIG. 52 QIAGEN N.V.: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 53 QIAGEN N.V.: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 54 DIASORIN: REVENUE, 20132015 ($MILLION)
FIG. 55 DIASORIN: REVENUE, BY GEOGRAPHY, 2015 (%)